Telomir Pharmaceuticals (NASDAQ: TELO) , an emerging leader in age-reversal science, announced significant findings from a preclinical progeria life ...
TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...